The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mamluk Roni since 2017.
This trader's CIK number is 1647053.
At the time of last reporting, Mamluk Roni was the President & CEO of Ayala Pharmaceuticals, Inc.. (stock ticker symbol AYLA).
Also see all insider trading activities at Ayala Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | AYLA | 0 | $0 | 53,998 | $930,896 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CHMA | 0 | $0 | 27,981 | $139,905 | 27,981 | $51,764 |
| 2020 | CHMA | 0 | $0 | 82,186 | $373,124 | 82,186 | $7,396 |
| 2019 | CHMA | 0 | $0 | 151,139 | $825,744 | 151,139 | $13,602 |
| 2018 | CHMA | 0 | $0 | 4,778 | $7,138 | 4,778 | $430 |
| 2017 | CHMA | 0 | $0 | 4,778 | $9,610 | 4,778 | $430 |
1. Ayala Pharmaceuticals, Inc. (AYLA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-22 | AYLA | Sale | 15,200 | 19.86 | 301,811 |
| 2021-02-23 | AYLA | Sale | 7,126 | 17.89 | 127,484 |
| 2021-02-24 | AYLA | Sale | 10,800 | 17.40 | 187,919 |
| 2021-01-20 | AYLA | Sale | 19,466 | 15.03 | 292,535 |
| 2021-01-21 | AYLA | Sale | 1,406 | 15.04 | 21,147 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-09 | CHMA | Option Ex | 27,981 | 1.85 | 51,764 |
| 2021-02-09 | CHMA | Sale | 27,981 | 5.00 | 139,905 |
| 2020-02-20 | CHMA | Sale | 82,186 | 4.54 | 373,124 |
| 2020-02-20 | CHMA | Option Ex | 82,186 | .09 | 7,396 |
| 2019-12-20 | CHMA | Option Ex | 61,139 | .09 | 5,502 |
| 2019-12-20 | CHMA | Sale | 61,139 | 5.51 | 336,875 |
| 2019-10-16 | CHMA | Sale | 10,000 | 4.94 | 49,400 |
| 2019-10-16 | CHMA | Option Ex | 10,000 | .09 | 900 |
| 2019-09-20 | CHMA | Option Ex | 50,000 | .09 | 4,500 |
| 2019-09-20 | CHMA | Sale | 50,000 | 5.59 | 279,500 |
| 2019-07-16 | CHMA | Option Ex | 10,000 | .09 | 900 |
| 2019-07-16 | CHMA | Sale | 10,000 | 6.35 | 63,500 |
| 2019-04-16 | CHMA | Option Ex | 10,000 | .09 | 900 |
| 2019-04-16 | CHMA | Sale | 10,000 | 5.31 | 53,099 |
| 2019-03-05 | CHMA | Option Ex | 5,000 | .09 | 450 |
| 2019-03-05 | CHMA | Sale | 5,000 | 5.00 | 25,000 |
| 2019-01-22 | CHMA | Option Ex | 5,000 | .09 | 450 |
| 2019-01-22 | CHMA | Sale | 5,000 | 3.67 | 18,370 |
| 2018-06-18 | CHMA | Sale | 2,389 | 1.46 | 3,483 |
| 2018-06-18 | CHMA | Option Ex | 2,389 | .09 | 215 |
| 2018-03-19 | CHMA | Option Ex | 2,389 | .09 | 215 |
| 2018-03-19 | CHMA | Sale | 2,389 | 1.53 | 3,655 |
| 2017-12-18 | CHMA | Option Ex | 2,389 | .09 | 215 |
| 2017-12-18 | CHMA | Sale | 2,389 | 1.75 | 4,180 |
| 2017-10-24 | CHMA | Option Ex | 2,389 | .09 | 215 |
| 2017-10-24 | CHMA | Sale | 2,389 | 2.27 | 5,430 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mamluk Roni (President & CEO of Ayala Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.